Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Return on Equity (2016 - 2025)

IGC Pharma has reported Return on Equity over the past 15 years, most recently at 0.01% for Q3 2025.

  • Quarterly Return on Equity rose 1.0% to 0.01% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Sep 2025, up 1.0% year-over-year, with the annual reading at 0.01% for FY2025, 0.0% changed from the prior year.
  • Return on Equity was 0.01% for Q3 2025 at IGC Pharma, up from 0.01% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q2 2021 and troughed at 0.02% in Q2 2024.
  • The 5-year median for Return on Equity is 0.01% (2023), against an average of 0.01%.
  • Year-over-year, Return on Equity decreased -1bps in 2024 and then rose 1bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then crashed by -93bps to 0.01% in 2022, then plummeted by -68bps to 0.01% in 2023, then decreased by -6bps to 0.01% in 2024, then rose by 30bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for IGC's Return on Equity are 0.01% (Q3 2025), 0.01% (Q2 2025), and 0.01% (Q1 2025).